Vetoquinol - Universal Registration Document - 2021

112 Vetoquinol Universal Registration Document 2020 Financial report 6 CONSOLIDATED FINANCIAL STATEMENTS Statutory auditor’s report on the consolidated financial statements Our response We have reviewed the main legal documents relating to this acquisition to identify the specific clauses likely to impact the allocation of the acquisition price. We have also reviewed the final report of the valuer concerning the final allocation of the purchase price. With the involvement of our valuation experts on the audit team, our work consisted, in particular in the context of the COVID-19 crisis, of: • evaluating the competence and independence of the evaluator assisting the Group in its work; • analyzing the methodology used by the Group to iden- tify the assets and liabilities assumed; • assessing the valuation methods and key assumptions used, especially in the valuation models for intangible assets; • performing sensitivity tests; • recalculating the data constituting the purchase price consideration on the basis of the items identified by Management. Finally, we assessed the appropriateness of the informa- tion provided in the notes to the consolidated financial statements. 6.6.4 Specific testing In accordance with professional standards applicable in France, we also carried out specific testing, as required by law and regulations, on the information relating to the Group provided in the management report prepared by the Board of Directors. We have no comment to make regarding the accuracy of this information or its consistency with the consolidated financial statements. We hereby certify that the consolidated statement of non-financial performance provided for in Article L.225- 102-1 of the French Commercial Code is included in the information relating to the Group in the management report, on the understanding that, in accordance with the provisions of Article L.823-10 of said Code, we have not assessed the information provided in this statement for fairness or consistency with the consolidated statements and this information must be the subject of a report by an independent third-party body. 6.6.5 Other specific testing as required by the laws and regulations in force Presentation format of the consolidated financial statements to be included in the annual financial report In accordance with III of Article 222-3 of the AMF General Regulation, the management of the company has infor- med us of its decision to postpone the application of the single electronic reporting format as defined by the Euro- pean Delegated Regulation No. 2019/815 of December 17, 2018 to financial years beginning on or after January 1, 2021. Consequently, this report does not include a conclusion on compliance with that format in the pre- sentation of the consolidated financial statements to be included in the annual financial report referred to in I of Article L.451-1-2 of the French Monetary and Financial Code. Appointment of the statutory auditors PricewaterhouseCoopers Audit was appointed statutory auditor of Vetoquinol SA by the shareholders’ general meeting of May 23, 1990, while Mazars was appointed by the shareholders’ general meeting of May 30, 2017. As of December 31, 2020, PricewaterhouseCoopers Audit was in its 31 st consecutive year as statutory auditor, inclu- ding 15 years since the Company shares were admitted for trading on a regulated market, while Mazars was in its fourth year as statutory auditor.